Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001607062-21-000537
Filing Date
2021-11-15
Accepted
2021-11-15 14:24:08
Documents
86
Period of Report
2021-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q clnh093021form10q.htm   iXBRL 10-Q 1436807
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 8828
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 9476
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 2603
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 2763
  Complete submission text file 0001607062-21-000537.txt   7283164

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE clnh-20210930.xsd EX-101.SCH 67104
7 XBRL CALCULATION FILE clnh-20210930_cal.xml EX-101.CAL 68171
8 XBRL DEFINITION FILE clnh-20210930_def.xml EX-101.DEF 208164
9 XBRL LABEL FILE clnh-20210930_lab.xml EX-101.LAB 417284
10 XBRL PRESENTATION FILE clnh-20210930_pre.xml EX-101.PRE 357615
11 EXTRACTED XBRL INSTANCE DOCUMENT clnh093021form10q_htm.xml XML 1298643
Mailing Address 55 IVAN ALLEN JR. BLVD NW #875 ATLANTA GA 30308
Business Address 55 IVAN ALLEN JR. BLVD NW #875 ATLANTA GA 30308 631-670-6777
Clinigence Holdings, Inc. (Filer) CIK: 0001479681 (see all company filings)

EIN.: 113363609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-53862 | Film No.: 211409170
SIC: 7389 Services-Business Services, NEC